CV
Chris Vazquez
Chief Accounting Officer

Chris Vazquez insider trades: Biodesix (BDSX) stock sales

Chief Accounting Officer, Biodesix Last trade Feb 10, 2026 19 Form 4 filings
$2K
Sold, last 12 months
3 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2023
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Chris reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 10, 2026BDSX↓ Sell$1K
Jan 16, 2026BDSX↓ Sell$676
Nov 10, 2025BDSX↓ Sell$99
Aug 13, 2025BDSX↓ Sell$95
May 13, 2025BDSX↓ Sell$80
Feb 11, 2025BDSX↓ Sell$3K
Nov 12, 2024BDSX↓ Sell$283
Aug 12, 2024BDSX↓ Sell$333
May 9, 2024BDSX↓ Sell$361
Feb 12, 2024BDSX↓ Sell$4K
Nov 10, 2023BDSX↓ Sell$268
Aug 10, 2023BDSX↓ Sell$742

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other BDSX insiders

Open-market trades in the last 12 months

About Chris Vazquez's insider trades

Chris Vazquez is Chief Accounting Officer at Biodesix (BDSX). Since Aug 10, 2023, Chris has reported no open-market purchases and 12 sales worth $11K on SEC Form 4. In the last 12 months: 3 sales ($2K).

Their filings also include option exercises (13 filings), grants and awards (7 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BDSX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.